Tag: biomarkers
-
Sensor Patch Tracks Chemical, Physical Vital Signs
24 May 2016. Engineers at University of California in San Diego developed a patch device worn on the skin with sensors that measure chemical indicators as well as physical vital signs. The UC-San Diego team that designed the device published its findings in yesterday’s issue of the journal Nature Communications. The researchers led by nanoengineering…
-
Venture Firm Funding Univ. Blood Diagnostics Technology
23 May 2016. A life sciences venture capital company is funding development of a technology at an Israeli research lab using DNA from blood tests to diagnose a range of diseases. Aurum Ventures is providing $1.2 million to Hebrew University of Jerusalem, through its technology transfer affiliate Yissum Research Development Company, for the university lab…
-
Tropical Disease Diagnostics Now on Market
12 April 2016. PATH research institute and medical test developer Standard Diagnostics are making available tests for the tropical diseases onchocerciasis and lymphatic filariasis. The rapid, point-of-care tests are designed to help health authorities in Africa and other regions better monitor the spread of the diseases in campaigns to eradicate their occurrence. Onchocerciasis is an…
-
Cancer Diagnostics Company Raises $12.3M in IPO
18 March 2016. VolitionRx, a developer of blood tests that screen for cancer and other disorders, is raising some $12.3 million in its initial public stock offering. The Namur, Belgium company, listed on the New York Stock Exchange under the symbol VNRX, issued about 3.8 million shares of common stock priced at $3.25. VolitionRx designs…
-
Biomarker Profiles Shown to Improve Ovarian Cancer Survival
14 March 2016. A clinical trial of people with ovarian cancer shows patients receiving treatments matching their particular molecular profiles survived an average of 9 months longer than those receiving one or more drugs not matching their biomarkers. Results of the study, conducted by Caris Life Sciences at 6 cancer care hospitals in the U.S.…
-
Study to Develop Simple, Standard TBI Test Process
9 March 2016. An industry, academic, and medical center research team is beginning a study to better diagnose traumatic brain injury with multiple testing methods. The project is an undertaking of medical device maker Abbott, Hennepin County Medical Center in Minneapolis, and University of Minnesota medical school, also in Minneapolis. The initiative aims to develop…
-
NSF Grant Funds Biosensing Laser Research
9 February 2016. An engineering professor at University of Texas in Arlington received a grant from National Science Foundation for research on lasers with fluid samples to detect indicators of disease. Yuze Sun, known as Alice, is the recipient of a $500,000 Faculty Early Career Development award from NSF, expected to run through 2020. Sun’s…
-
Test IDs Mesothelioma Years Before Symptoms Appear
5 February 2016. A company spun-off from Purdue University designed a test that in a recent study detects cases of mesothelioma, a form of lung cancer, several years before symptoms develop. Results of the study conducted by MorNuCo Laboratories in West Lafayette, Indiana appear in the 22 January issue of the journal Clinical Proteomics. Mesothelioma is…
-
Phillips, Banyan Partner on Point-of-Care Concussion Test
7 January 2016. A collaboration between electronics manufacturer Royal Phillips and medical diagnostics company Banyan Biomarkers Inc. is developing a handheld blood test for concussions and other mild traumatic brain injuries. Financial and intellectual property aspects of the partnership were not disclosed. Traumatic brain injury is caused by a blow or jolt to the head,…
-
Penn, Epic Sciences Partner on Liquid Biopsies
13 November 2015. University of Pennsylvania’s medical school plans to apply liquid biopsy technology developed by Epic Sciences to gain a more detailed understanding of different cancers for individual patient therapies. Financial terms of the agreement between the university and the San Diego biotechnology company were not disclosed. Epic Sciences’s technology detects and analyzes circulating…